Protocol approach 3: comprehensive repair (thymosin alpha-1 plus BPC-157 plus TB-500) Goal: Immune rebalancing combined with aggressive tissue repair Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week BPC-157: 250 mcg subcutaneously twice daily near affected tissue TB-500 : 2-5 mg subcutaneously twice per week for loading, then weekly for maintenance Rationale: This three-peptide approach targets immune regulation (TA1), mucosal and tissue healing (BPC-157), and cellular migration plus repair (TB-500)
The peptide also supports the growth and development of new brain cells by increasing specific markers like Nestin and GAP43 in human stem cells (4)
Meanwhile, firefighters are hopeful these changes will mean better access to glutathione as soon as possible
Today it is approved in more than 45 countries for conditions including ischemic stroke, traumatic brain injury (TBI), and various forms of dementia
Patients with active infections, certain autoimmune conditions, active malignancy, or pregnancy are typically not candidates and these are screened at consultation
